Cargando…
A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
Agonists for toll-like receptors (TLRs) have shown promising activities against cancer. In the present study, a squalene-based nanoemulsion (NE) was loaded with resiquimod, a TLR7/8 agonist for therapeutic delivery. R848 NE was developed and characterized for long-term stability. In vitro and in viv...
Autores principales: | Zhang, Zhongkun, Kuo, Jimmy Chun-Tien, Zhang, Chi, Huang, Yirui, Zhou, Zerui, Lee, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706843/ https://www.ncbi.nlm.nih.gov/pubmed/34959344 http://dx.doi.org/10.3390/pharmaceutics13122060 |
Ejemplares similares
-
Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
por: Zhang, Chi, et al.
Publicado: (2022) -
Improving the Stability and Effectiveness of Immunotropic Squalene Nanoemulsion by Adding Turpentine Oil
por: Krasnova, Olga A., et al.
Publicado: (2023) -
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021) -
The Droplet-Size Effect Of Squalene@cetylpyridinium Chloride Nanoemulsions On Antimicrobial Potency Against Planktonic And Biofilm MRSA
por: Fang, Jia-You, et al.
Publicado: (2019) -
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
por: Zhang, Zhongkun, et al.
Publicado: (2021)